Search Results
Apr 15, 2026, 06:00 ET Aegea maintains sustainable growth, with pro forma net revenue of R$ 18 billion, a 21% increase compared to 2024.
operational efficiency. The Company also advanced in governance and access to capital markets, with the conversion of its registration to category "A" at the CVM, increasing flexibility for future fundraising.According to André Pires, CFO of Aegea, "This performance reflects the maturity of our portfolio
More news about: Aegea Saneamento
Apr 15, 2026, 06:00 ET Aegea mantém crescimento sustentável, com receita líquida pró forma do Ecossistema de R$ 18 bilhões, aumento de 21% se comparado à 2024.
sua evolução contínua. A Companhia também avançou em sua governança e acesso ao mercado de capitais, com a conversão do registro para categoria "A" na CVM, ampliando sua flexibilidade para futuras captações.Segundo André Pires, CFO da Aegea, "Esse desempenho reflete o amadurecimento do nosso portfólio
More news about: Aegea Saneamento
Apr 07, 2026, 12:38 ET Ecosystems Appoints Paige O'Neill, Chief Marketing Officer of Culture Amp, to Board of Directors
WASHINGTON, April 7, 2026 /PRNewswire/ -- Ecosystems, the pioneer of the Customer Value Management (CVM) category, is excited to announce the appointment of Paige O'Neill, Chief Marketing Officer at Culture Amp, to its Board of Directors.
More news about: Ecosystems
Mar 31, 2026, 03:00 ET Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
the personal wellness, veterinary, and pharmaceutical sectors. In veterinary medicine, this commitment is reflected in concrete results -- including CVM recognition of Innocan's innovative LPT technology targeting chronic pain in animals, validated by a placebo-controlled study published in a leading
More news about: Innocan Pharma Corporation
Mar 31, 2026, 03:00 ET Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
the personal wellness, veterinary, and pharmaceutical sectors. In veterinary medicine, this commitment is reflected in concrete results — including CVM recognition of Innocan's innovative LPT technology targeting chronic pain in animals, validated by a placebo-controlled study published in a leading
More news about: Innocan Pharma Corporation
Mar 13, 2026, 17:36 ET GERDAU S.A. - FORMULÁRIO 20-F
and Exchange Comission (SEC) (http://sec.gov) e à Comissão de Valores Mobiliários (CVM) (http://cvm.gov.br). O documento também está disponível no site de Relações com Investidores
More news about: Gerdau S.A.
Mar 13, 2026, 17:31 ET GERDAU S.A. - FORM 20-F
Commission (SEC) at http://sec.gov and the Brazilian Securities and Exchange Commission (CVM) at http://cvm.gov.br. The document is also available on the Company's Investor Relations
More news about: Gerdau S.A.
Mar 06, 2026, 19:06 ET Embraer S.A. Announces MATERIAL FACT
December 15, 1976, as amended ("Brazilian Corporate Law"), as well as under Resolution No. 44 of August 23, 2021, as amended, and Resolution CVM No. 77 of March 29, 2022 ("CVM Resolution 77"), hereby informs its shareholders and the market in general that: The share buyback program approved by the Board
More news about: Embraer S.A.
Mar 06, 2026, 07:07 ET EMBRAER S.A. Announces MATERIAL FACT
December 15, 1976, as amended ("Brazilian Corporate Law"), as well as under Resolution No. 44 of August 23, 2021, as amended, and Resolution CVM No. 77 of March 29, 2022 ("CVM Resolution 77"), informs its shareholders and the market in general that the Board of Directors, in a meeting held on this date, March
More news about: Embraer S.A.
Mar 06, 2026, 05:06 ET Embraer S.A. Announces MATERIAL FACT
/PRNewswire/ -- EMBRAER S.A. ("Embraer" or "Company") (B3: EMBJ3, NYSE: EMBJ), in compliance with CVM Resolution No. 44/2021 and CVM Resolution nº No. 44/2022, hereby informs its shareholders and the market in general of the projections for 2026.
More news about: Embraer S.A.
Mar 03, 2026, 14:11 ET Lifecycle lance NEXUS® IQ au MWC : l'IA native au service des opérateurs de télécoms transforme les données d'événement en parcours de revenus
données en informations exploitables et d'améliorer les performances à chaque étape du parcours du client. »NEXUS® IQ fait évoluer les capacités CVM des produits de Lifecycle Software et les associe aux modèles et capacités d'IA de pointe de SourseAI
More news about: Lifecycle Software Ltd
Mar 02, 2026, 20:17 ET Lifecycle stellt NEXUS® IQ auf dem MWC vor: Telco-native KI verwandelt Ereignisdaten in Umsatzströme
Betriebsteams, Daten in umsetzbare Erkenntnisse umzuwandeln und so die Leistung in jeder Phase der Customer Journey zu steigern."NEXUS® IQ erweitert die CVM-Funktionen der Produkte von Lifecycle Software und kombiniert sie mit modernsten KI-Modellen und -Funktionen von
More news about: Lifecycle Software Ltd
Mar 02, 2026, 14:59 ET Lifecycle lanza NEXUS® IQ en MWC: IA nativa de telecomunicaciones
los datos en información práctica, impulsando el rendimiento en cada etapa del recorrido del cliente".NEXUS® IQ desarrolla las capacidades de CVM de los productos de Lifecycle Software y las combina con modelos de IA de vanguardia y las capacidades de
More news about: Lifecycle Software Ltd
Mar 02, 2026, 11:58 ET Lifecycle launches NEXUS® IQ at MWC: Telco-native AI turning event data into revenue journeys
operations teams to transform data into actionable insight, driving performance across every stage of the customer journey."NEXUS® IQ evolves the CVM capabilities of Lifecycle Software's products and combines it with leading edge AI models and capabilities from
More news about: Lifecycle Software Ltd
Mar 02, 2026, 11:49 ET Lifecycle launches NEXUS® IQ at MWC: Telco-native AI turning event data into revenue journeys
operations teams to transform data into actionable insight, driving performance across every stage of the customer journey."NEXUS® IQ evolves the CVM capabilities of Lifecycle Software's products and combines it with leading edge AI models and capabilities from
More news about: Lifecycle Software Ltd
Feb 27, 2026, 16:57 ET BANCO SANTANDER (BRASIL) S.A Publicly-Held Company with Authorized Capital
Securities and Exchange Commission, or the SEC, and with the Brazilian Securities and Exchange Commission, the Comissão de Valores Mobiliários, or CVM, on February 27, 2026. The document has been posted on Santander Brasil's website, https://www.santander.com.br/ri.
More news about: BANCO SANTANDER (BRASIL) S.A.
Feb 27, 2026, 16:30 ET FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver for its LPT-CBD (Liposome Platform Technology-Cannabidiol) product for the third consecutive year.
More news about: Innocan Pharma Corporation
Feb 27, 2026, 16:30 ET FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine (CVM) has granted the Company a sponsor fee waiver for its LPT-CBD (Liposome Platform Technology-Cannabidiol) product for the third consecutive year.
More news about: Innocan Pharma Corporation
Feb 27, 2026, 10:38 ET Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics
off-the-shelf veterinary stem cell therapy, pending conditional approval by the U.S. Food and Drug Administration Center for Veterinary Medicine (FDA-CVM). Together, the companies are laying the foundation for a new category of veterinary care.The first expected product from Gallant's
More news about: Gallant
Feb 23, 2026, 17:13 ET GERDAU S.A. - INFORMAÇÕES CONSOLIDADAS
arquivando hoje o documento contendo os Resultados do 4T25 na Securities and Exchange Commission (SEC) e na Comissão de Valores Mobiliários (CVM) e se encontra disponível em nosso site. Para acessar o referido documento clique em:
More news about: Gerdau S.A.
Feb 23, 2026, 17:10 ET GERDAU S.A. - CONSOLIDATED INFORMATION
GGBR4) informs that it is filling today its 4Q25 results at the Securities and Exchange Commission (SEC) and at the Comissão de Valores Mobiliários (CVM), which are available at Gerdau's website. To access this document, please click on:
More news about: Gerdau S.A.
Feb 09, 2026, 09:07 ET Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
pain management in both veterinary and human settings. We have initiated ongoing discussions with FDA, including the Center for Veterinary Medicine (CVM) and the human analgesic and anesthetic department of the FDA, to support the advancement of LPT-CBD across both markets."Reference:(1)
More news about: Innocan Pharma Corporation
Feb 09, 2026, 09:07 ET Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
pain management in both veterinary and human settings. We have initiated ongoing discussions with FDA, including the Center for Veterinary Medicine (CVM) and the human analgesic and anesthetic department of the FDA, to support the advancement of LPT-CBD across both markets."Reference:(1)
More news about: Innocan Pharma Corporation
Feb 04, 2026, 18:22 ET ITAÚ UNIBANCO - Material Fact: Guidance 2026
compliance with the provisions of Article 157, paragraph 4 of Law No. 6,404/76 and Resolution No. 44/21 of the Brazilian Securities and Exchange Commission (CVM), informs its stockholders and the market in general that it released as of this date its projections for the year 2026 in accordance with item 3 ("Projections")
More news about: Itaú Unibanco Holding S.A.
Feb 04, 2026, 17:54 ET Itaú Unibanco - Fato Relevante: Programa Recompra de Ações
intermediadas pela Itaú Corretora de Valores S.A.Gustavo Lopes RodriguesDiretor de Relações com InvestidoresAnexo G da Resolução CVM Nº 80/22Negociação de Ações de Própria Emissão1. Justificar pormenorizadamente o objetivo e os efeitos econômicos esperados
More news about: Itaú Unibanco Holding S.A.